Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane for Breast Cancer Prevention in High-Risk Postmenopausal Women
NCT00073073Phase 2Completed
- Sponsor
- Georgetown University
- Start
- Nov 2003
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exemestane in breast cancer, sponsored by Georgetown University. Started Nov 2003; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00073073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073073.